Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins

Mostrar otras versiones (1)

Progressive reduction in kidney function in patients following myocardial infarction (MI) is associated with an increase in circulating uremic toxins levels leading to increased extracellular matrix deposition. We have recently reported that treatment with uremic toxin adsorbent AST-120 in rats with...

Descripción completa

Detalles Bibliográficos
Autores principales: Rana, Indrajeetsinh, Kompa, Andrew R, Skommer, Joanna, Wang, Bing H, Lekawanvijit, Suree, Kelly, Darren J, Krum, Henry, Charchar, Fadi J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425975/
https://www.ncbi.nlm.nih.gov/pubmed/25896982
http://dx.doi.org/10.14814/phy2.12371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425975/
https://www.ncbi.nlm.nih.gov/pubmed/25896982
http://dx.doi.org/10.14814/phy2.12371

Ejemplares similares